BIG
EVH icon

Brooklyn Investment Group’s Evolent Health EVH Stock Holding History

Brooklyn Investment Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-54
Closed -$609 – 1321
2025
Q2 		$609 Sell
54
-20
-27% -$184 ﹤0.01% 3049
2025
Q1 		$701 Buy
+74
New +$747 ﹤0.01% 2442

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brooklyn Investment Group's EVH Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 54 shares — an estimated $609 sold.

Brooklyn Investment Group first reported a position in EVH in Q1 2025 and held it in 2 quarters. The position peaked at $701 in Q1 2025. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 54 Evolent Health shares in Q3 2025, an estimated $609.
  • Brooklyn Investment Group first reported a position in Evolent Health in Q1 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Evolent Health position peaked at $701 in Q1 2025.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.